Upcoming Events

June

22

NCI Drug Development Workshop II: Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs

10:00 AM

June 22 - July 28, select Thursdays & Fridays

Virtual Webinar

Review Agenda and RSVP

June

29

UCI Anti-Cancer Challenge Webinar: Shaping the Future of Women's Health with Innovations in Reproductive and Breast Cancer Research

1:00 - 2:00 PM

Virtual Webinar

Learn More or Join via Zoom

 

Announcements

Oncology Services Program Received the Highest Recognition for Clinical Care, the ASCO Quality Oncology Practice Initiative (QOPI) Certification


Congratulations to Dr. Edward L. Nelson, chief of hematology-oncology, and the physicians, nurses, pharmacists, social workers and cancer center teammates who work together to meet these high standards of quality cancer care each day while providing disease-specific expertise.

We are pleased to announce that the Publication Rebate Program has been extended through 2023!


CFCCC is offering a $250 rebate towards publication costs for manuscripts that: (1) are cancer-related, (2) are accepted for publication in a peer-reviewed journal between April 1, 2019 and December 31, 2023, (3) appropriately acknowledge a CFCCC-supported Shared Resource, and (4) cite the P30CA062203 Cancer Center Support Grant. Please submit your publication for this rebate program through this link.


Please join us in congratulating the following Cancer Center members for their recent cancer-relevant publications and successful utilization of the Publication Rebate Program. 

Name

Publication Title & Shared Resource(s) Used

Farouk Nouizi, PhD

(Biotechnology, Imaging & Drug Development)

Acknowledged use of In Vivo Functional Onco-Imaging Shared Resource.


Development of a theranostic preclinical fluorescence molecular tomography/cone beam CT-guided irradiator platform (Biomedical Optics Express).


Development of a preclinical CCD-based temperature modulated fluorescence tomography platform (Biomedical Optics Express).

Ling Gao, PhD

(Biotechnology, Imaging & Drug Development)

Acknowledged use of Optical Biology Core - Flow Cytometry Facility.


Selective Inhibition of Aurora Kinase A by AK-01/LY3295668 Attenuates MCC Tumor Growth by Inducing MCC Cell Cycle Arrest and Apoptosis (Cancers).

Save The Date: UCI Anti-Cancer Challenge


Saturday, Oct. 7 at UCI Aldrich Park | 5K and 10K Run/Walk | 14-, 35-, 60- and 100-Mile Ride | Mountain Bike Ride


The UCI Anti-Cancer Challenge is a community movement to raise awareness and funds for critical cancer research at the UCI Health Chao Family Comprehensive Cancer Center. Every participant-raised dollar directly funds pilot studies and early phase clinical trials that aim to develop new insights into cancer prevention, treatment and cures — to save lives

Learn More and Register

Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Now Available


Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs. After you have booked the meeting, the Zoom information will be sent to you if you would like to meet via Zoom. Please note that walk-in services will not be available June 12 - July 1.


Questions? Contact Wen-pin Chen, Senior Statistician and BSR Manager.

Book Your Consultation
 

Funding Opportunities

OTHER NON-FEDERAL FUNDING OPPORTUNITIES


These opportunities do not require nomination or selection by the Cancer Center.

Prevent Cancer Foundation Research Grants & Fellowships

$100K/2 years

Focus: Innovative research in cancer prevention and early detection

Proposal Due: July 11, 2023

Learn More and Apply >>



California Breast Cancer Research Program (CBCRP)

Convener on Fertility Preservation for Young Breast Cancer Patients

$40K/6 months

Application: August 2, 2023

Learn More and Apply >>


California Breast Cancer Research Program (CBCRP)

Shift Work and Breast Cancer Risk

$300K (Project 1); $350K (Project 2)/2 years

Application: August 2, 2023

Learn More and Apply >>


Minnesota Ovarian Cancer Alliance (MOCA)

2023 National Early Detection of Ovarian Cancer Research Awards

$150K/1 year

Focus: early detection of ovarian, primary peritoneal, or fallopian tube cancer

Proposal: September 1, 2023

Learn More and Apply >>

FEDERAL FUNDING OPPORTUNITIES

Congressionally Directed Medical Research Programs


FY23 Breast Cancer Research Program (BCRP) - earliest deadline June 29, 2023

(NEW) FY23 Kidney Cancer Research Program (KCRP) - earliest deadline July 20, 2023

FY23 Lung Cancer Research Program (LCRP): Patient-Centered Outcomes and Survivorship Award (PCOSA) – July 20, 2023

FY23 Melanoma Research Program (MRP) - earliest deadline July 10, 2023

FY23 Pancreatic Cancer Research Program (PCARP) - earliest deadline July 10, 2023

FY23 Peer Reviewed Cancer Research Program (PRCRP) – next deadline July 25, 2023

FY23 Prostate Cancer Research Program (PCRP) – earliest deadline June 22, 2023

FY23 Rare Cancers Research Program (RCRP) - earliest deadline June 26, 2023

 

Newsroom

Survival Machine Learning for Breast Cancer Patients


Racial disparities can exist even in machine learning.

Jung In Park, assistant professor in the Sue & Bill Gross School of Nursing, finds a way to tackle biases and make a difference for vulnerable populations. Her research area focuses on biomedical informatics using large datasets and AI/machine learning approaches to provide scientific evidence for predicting patient outcomes.


Read More >>

Rise in Colorectal Cancer Among Young Adults an Alarming Trend


The rise in colon cancer rates among millennials has been alarming. "Physicians are aware, primary care doctors are aware, oncologists are aware, and I am not sure the public is aware that it is a real issue," said Dr. Jason Zell, Professor at UC Irvine Health Chao Family Comprehensive Cancer Center.


Read More >>

UC Irvine study finds that lesbian, gay and bisexual cancer survivors experience more health-related challenges compared to heterosexual counterparts


Corresponding author Michael Hoyt, PhD, associate professor of population health and disease prevention from UCI’s Program in Public Health, and his collaborators published their findings in the Journal of Psychosocial Oncology. 


Read More >>

Questions? Contact us at cfcccadmin@hs.uci.edu